Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: indication (643), sign (706), indicator (112)

Fulvestrant-Ribociclib

Description: Chemotherapy Protocol Breast Cancer Fulvestrant-Ribociclib Regimen • Breast Cancer – Fulvestrant-Ribociclib Indication • Fulvestrant and ribociclib is indicated for oestrogen receptor-positive
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Fulvestrant-Ribociclib.pdf

Induction of labour - patient information

Description: Induction of labour Contents What is induction of labour? page 3 Reasons for induction page 3 If you are 12
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Induction-of-labour.pdf

Supplier representative procedure

Description: Procurement and supply chain and the commercial development team appreciate the role that companies play to assist the Trust in providing
Url: /Media/UHS-website-2019/Docs/Policies/Supplier-representative-procedure.pdf

Docetaxel-Pertuzumab/TrastuzumabSC

Description: Chemotherapy Protocol BREAST CANCER Docetaxel-Pertuzumab/Trastuzumab SC Regimen • Breast Cancer – Docetaxel-Pertuzumab/Trastuzumab SC Indication •
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-PertuzumabTrastuzumabSC.pdf

HSCTCyclophosphamideTBI_Related_Methotrexate_GvHD

Description: Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT CYCLOPHOSPHAMIDE-TOTAL BODY IRRADIATION (TBI)-METHOTREXATE (GvHD) Related Donor Conditioning This r
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTCyclophosphamideTBI-Related-Methotrexate-GvHD.pdf

HSCTAlemtuzumabCyclophosphamideTBI_VUD_Methotrexate_GvHD

Description: Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT ALEMTUZUMAB-CYCLOPHOSPHAMIDE-TOTAL BODY IRRADIATION (TBI)METHOTREXATE (GvHD) Volunteer Unrelated Do
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTAlemtuzumabCyclophosphamideTBI-VUD-Methotrexate-GvHD.pdf

UHS Green Plan 2025-2028

Description: Green Plan 2025 - 2028 Approved November 2025 Contents 1 Executive Summary 2 Introduction and Context 3 Organisational Vision 4 Review of Progress 20
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Sustainability-and-Green-Plan/UHS-Green-Plan-2025-2028.pdf

National maternity survey 2024 - UHS NHS FT benchmarking report

Description: NHS Maternity Services Survey 2024 Benchmark Report University Hospital Southampton NHS Foundation Trust 1 Maternity Survey 2024 | RHM | University
Url: /Media/UHS-website-2019/Docs/Services/Maternity/National-maternity-survey-2024-UHS-NHS-FT-benchmarking-report.pdf

Carboplatin Paclitaxel EC Pembrolizumab Neoadjuvant Ver1.0

Description: Chemotherapy Protocol BREAST CANCER PEMBROLIZUMAB WITH CARBOPLATIN/PACLITAXEL AND EC NEOADJUVANT BREAST CANCER FOLLOWED BY ADJUVANT PEMBROLIZU
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Paclitaxel-EC-Pembrolizumab-Neoadjuvant.pdf

Carfilzomib Dexamethasone(40) Lenalidomide

Description: Chemotherapy Protocol MYELOMA Carfilzomib -Lenalidomide -Dexamethasone Regimen • Myeloma – Carfilzomib-Lenalidomide-Dexamethasone Indication • Car
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Carfilzomib-Dexamethasone40-Lenalidomide.pdf

111 to 120 of 133

Previous … 10 11 12 13 14 Next